SFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease

S. Warrier, R. Marimuthu, S. Sekhar, G. Bhuvanalakshmi, Frank Arfuso, A.K. Das, R. Bhonde, Ralph Martins, A. Dharmarajan

    Research output: Contribution to journalReview article

    13 Citations (Web of Science)


    © 2016 Elsevier Ltd. All rights reserved. The extracellular ligand, Wnt, and its receptors are involved in sign al transduction and play an important role in axis formation and neural development. In neurodegenerative disorders such as Alzheimer's disease (AD), a decrease of the intracellular Wnt effector, β-catenin, has been linked to amyloid-β-peptide-induced neurotoxicity. Despite this knowledge, targeting Wnt inhibitors as potential biomarkers has not been explored, and harnessing Wnt activators as therapeutic candidates remains largely not investigated. A wide acting family of Wnt mediators, secreted frizzled-related proteins (sFRPs), has not been probed so far as molecular indicators of disease occurrence and progression of Alzheimer's. Unlike the effect of the Dickkopf (DKK) family of Wnt antagonists on AD, the sFRP molecules have a more pleiotropic impact on the Wnt signaling cascade and probably have a far-reaching involvement in neurodegeneration. The role of sFRPs has been poorly described in AD, and in this review, we analyze the present status of the role of sFRPs on neurodegeneration, their likely involvement, and potential implications in treatment modalities of AD. This information would provide valuable clues for the development of potential therapeutic targets for aberrant neurodegenerative disorders.
    Original languageEnglish
    Pages (from-to)104-111
    Number of pages8
    JournalInternational Journal of Biochemistry and Cell Biology
    Publication statusPublished - 2016


    Dive into the research topics of 'SFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease'. Together they form a unique fingerprint.

    Cite this